Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Langer

Showing results (41-50 of 160) with videos related to

Pageof 16
Sort By:
Pharmaceutics|July 2, 2021
Imaging-Based Characterization of a <i>Slco2b1<sup>(-/-)</sup></i> Mouse Model Using [<sup>11</sup>C]Erlotinib and [<sup>99m</sup>Tc]Mebrofenin as Probe SubstratesSolène Marie, Irene Hernández-Lozano, Louise Breuil, et al.
European Journal of Microbiology & Immunology|October 23, 2018
Humanization of the Blood-Brain Barrier Transporter ABCB1 in Mice Disrupts Genomic Locus - Lessons from Three Unsuccessful ApproachesMarkus Krohn, Thomas Wanek, Marie-Claude Menet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2015
Breast Cancer Resistance Protein and P-Glycoprotein Influence In Vivo Disposition of 11C-ErlotinibAlexander Traxl, Thomas Wanek, Severin Mairinger, et al.
EJNMMI Research|October 18, 2012
Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood-brain barriers studied with (R)-[11C]verapamil positron emission tomographyJulia Müllauer, Claudia Kuntner, Martin Bauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2018
P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of <sup>11</sup>C-Metoclopramide Across the Blood-Brain Barrier: A PET Study on Nonhuman PrimatesSylvain Auvity, Fabien Caillé, Solène Marie, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 9, 2021
Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice?Louise Breuil, Solène Marie, Sébastien Goutal, et al.
Molecular Pharmaceutics|April 20, 2013
Factors that limit positron emission tomography imaging of p-glycoprotein density at the blood-brain barrierPavitra Kannan, Victor W Pike, Christer Halldin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 15, 2016
Assessment of P-Glycoprotein Transport Activity at the Human Blood-Retina Barrier with (<i>R</i>)-<sup>11</sup>C-Verapamil PETMartin Bauer, Rudolf Karch, Nicolas Tournier, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 17, 2009
Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrierMartin Bauer, Rudolf Karch, Friederike Neumann, et al.
Pharmaceutical Research|February 9, 2021
Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [<sup>11</sup>C]Metoclopramide in MiceIrene Hernández-Lozano, Severin Mairinger, Michael Sauberer, et al.
Pageof 16

Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
Pharmaceutics|July 2, 2021
Imaging-Based Characterization of a <i>Slco2b1<sup>(-/-)</sup></i> Mouse Model Using [<sup>11</sup>C]Erlotinib and [<sup>99m</sup>Tc]Mebrofenin as Probe SubstratesSolène Marie, Irene Hernández-Lozano, Louise Breuil, et al.
European Journal of Microbiology & Immunology|October 23, 2018
Humanization of the Blood-Brain Barrier Transporter ABCB1 in Mice Disrupts Genomic Locus - Lessons from Three Unsuccessful ApproachesMarkus Krohn, Thomas Wanek, Marie-Claude Menet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2015
Breast Cancer Resistance Protein and P-Glycoprotein Influence In Vivo Disposition of 11C-ErlotinibAlexander Traxl, Thomas Wanek, Severin Mairinger, et al.
EJNMMI Research|October 18, 2012
Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood-brain barriers studied with (R)-[11C]verapamil positron emission tomographyJulia Müllauer, Claudia Kuntner, Martin Bauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2018
P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of <sup>11</sup>C-Metoclopramide Across the Blood-Brain Barrier: A PET Study on Nonhuman PrimatesSylvain Auvity, Fabien Caillé, Solène Marie, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 9, 2021
Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice?Louise Breuil, Solène Marie, Sébastien Goutal, et al.
Molecular Pharmaceutics|April 20, 2013
Factors that limit positron emission tomography imaging of p-glycoprotein density at the blood-brain barrierPavitra Kannan, Victor W Pike, Christer Halldin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 15, 2016
Assessment of P-Glycoprotein Transport Activity at the Human Blood-Retina Barrier with (<i>R</i>)-<sup>11</sup>C-Verapamil PETMartin Bauer, Rudolf Karch, Nicolas Tournier, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 17, 2009
Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrierMartin Bauer, Rudolf Karch, Friederike Neumann, et al.
Pharmaceutical Research|February 9, 2021
Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [<sup>11</sup>C]Metoclopramide in MiceIrene Hernández-Lozano, Severin Mairinger, Michael Sauberer, et al.
Pageof 16